| Literature DB >> 35563287 |
Carolina Johnstone1, Elena Chaves-Pozo2.
Abstract
Infectious diseases are a burden for aquaculture. Antigen processing and presentation (APP) to the immune effector cells that fight pathogens is key in the adaptive immune response. At the core of the adaptive immunity that appeared in lower vertebrates during evolution are the variable genes encoding the major histocompatibility complex (MHC). MHC class I molecules mainly present peptides processed in the cytosol by the proteasome and transported to the cell surface of all cells through secretory compartments. Professional antigen-presenting cells (pAPC) also express MHC class II molecules, which normally present peptides processed from exogenous antigens through lysosomal pathways. Autophagy is an intracellular self-degradation process that is conserved in all eukaryotes and is induced by starvation to contribute to cellular homeostasis. Self-digestion during autophagy mainly occurs by the fusion of autophagosomes, which engulf portions of cytosol and fuse with lysosomes (macroautophagy) or assisted by chaperones (chaperone-mediated autophagy, CMA) that deliver proteins to lysosomes. Thus, during self-degradation, antigens can be processed to be presented by the MHC to immune effector cells, thus, linking autophagy to APP. This review is focused on the essential components of the APP that are conserved in teleost fish and the increasing evidence related to the modulation of APP and autophagy during pathogen infection.Entities:
Keywords: LC3-Associated phagocytosis; MHC class II; antigen processing; antigen-presenting cell; bacteria; chaperone-mediated autophagy; macroautophagy; major histocompatibility complex MHC class I; vaccine; virus
Mesh:
Substances:
Year: 2022 PMID: 35563287 PMCID: PMC9103719 DOI: 10.3390/ijms23094899
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Major histocompatibility complex (MHC) class I and II antigen processing and presentation (APP) and autophagy. MHC class I presents endogenous peptides produced in the cytosol (peptide represented by a circle) or in secretory compartments (star) to CD8 + T lymphocytes through the pathways indicated with the dashed arrows. Endogenously synthesized proteins and defective ribosomal products (DRiPs) are processed to peptides in the cytosol by the proteasome and cytosolic proteases. Peptides are then transported by transporter associated to antigen processing (TAP) to the ER where the peptide loading complex (PLC) is formed by a peptide, TAP, MHC class I, β2-microglobulin (β2m) and other assistant proteins. Endogenous proteins can enter the lumen of the ER through the translocon and be processed by proteases of the ER or the Golgi network (GN), thus, producing peptides that can also be loaded on MHC class I beyond the ER. Loaded MHC class I molecules are transported to the cell surface in secretory vesicles. MHC class I can also cross present peptides and prime CD8+ T lymphocytes through the pathway indicated with the dotted arrows. Cross-presented peptides (triangle) are produced by processing exogenous antigens in the cytosol or in secretory or endocytic compartments in which autophagy (A) may take place. MHC class II presents peptides (diamond) processed from exogenous proteins to CD4 + T lymphocytes through the pathway indicated with the continuous lined arrows. In the ER, MHC class II molecules are assembled and bind to the invariant chain li. The MHC class II is exported to endosomal compartments, in which autophagy can take place and where class II-associated invariant chain peptide (CLIP) remains bound to MHC class II after cleavage of li by lysosomal cathepsins. HLA-DM assists in the exchange of CLIP by a peptide that is exported to the cell surface through exocytic vesicles. Chaperone-mediated autophagy allows the targeting of cytosolic proteins to be degraded in lysosomes and is assisted by Lamp2a, Hsp70 and other chaperones. Macroautophagy is the engulfment of diverse cytosolic material to be degraded, induced by inhibition of the mammalian target of rapamycin (mTOR). Several multiprotein complexes (ULK, PI3K and ATG16L1) are involved in the formation of vesicles and lipidation of LC3-I to LC3-II, thereby, forming autophagosomes that fuse with lysosomes.
Modulation of expression of genes involved in antigen processing and presentation (APP) MHC class I and II pathways and autophagy during infection of teleost fish species with viral pathogens.
| Virus 1 | Host Species | MHC I 2 APP | MHC II 2 APP | Autophagy 2 | Organ or Cell | Reference |
|---|---|---|---|---|---|---|
| VHSV |
| n.d. | − | n.d. | Brain cell line. | [ |
|
| + | n.d. | n.d. | Skin fibroblast cell line. | [ | |
|
| + | n.d. | n.d. | Skin fibroblast cell line. | [ | |
| + | + | + | Red blood cells and head-kidney. | [ | ||
| n.d. | + | n.d. | Blood and spleen B cells. | [ | ||
|
| n.d. | n.d. | + | Red blood cells. | [ | |
|
| n.d. | n.d. | + | Kidney and spleen. | [ | |
| NNV |
| + | n.d. | n.d. | Liver and spleen. | [ |
|
| + | − | −/+ | Larvae. | [ | |
| CSV |
| + | n.d. | n.d. | Monocyte/macrophage cell line. | [ |
| GCRV |
| n.d. | n.d. | + | Kidney cell line. | [ |
| SGIV |
| + | n.d. | n.d. | Liver and spleen. | [ |
| IHNV |
| + | − | n.d. | Spleen, intestines and head-kidney. | [ |
| RBIV |
| n.d. | + | n.d. | Kidney and spleen. | [ |
| SAV3 |
| + | n.d. | n.d. | Pancreas, heart, spleen, head-kidney, liver and gills. | [ |
| ISKNV |
| + | n.d. | n.d. | Head-kidney, spleen and liver. | [ |
1 Viral pathogens: Chum Salmon Reovirus (CSV), Grass carp reovirus (GCRV), Infectious hematopoietic necrosis virus (IHNV), Infectious spleen and kidney necrosis virus (ISKNV), Nervous Necrosis Virus (NNV), rock bream iridovirus (RBIV), RNA virus salmonid alpha virus 3 (SAV3), Singapore grouper iridovirus (SGIV), Viral Hemorrhagic Septicemia Virus (VHSV); 2 Expression of genes related to APP MHC class I pathways, APP MHC class II pathways or autophagy were (+) upregulated, (−) downregulated or (n.d.) not determined.
Modulation of expression of genes involved in antigen processing and presentation (APP) MHC class I and II pathways and autophagy during infection of teleost fish species by bacteria or eukaryote parasites.
| Pathogen 1 | Host Species | MHC I 2 APP | MHC II 2 APP | Autophagy 2 | Organ or Cell | Reference |
|---|---|---|---|---|---|---|
|
|
| +/(=) | n.d. | n.d. | Heart, spleen, head-kidney, liver and gill. | [ |
|
|
| + | n.d. | − | Lymphocytes from peripheral blood, head-kidney and spleen. | [ |
|
| n.d. | + | n.d. | Head-kidney leucocytes. | [ | |
|
| n.d. | + | n.d. | Kidney and liver. | [ | |
|
| n.d. | + | n.d. | Liver, spleen and kidney. | [ | |
|
| + | n.d. | n.d. | Head-kidney, spleen and liver. | [ | |
|
|
| n.d. | + | n.d. | Head-kidney and spleen. | [ |
|
|
| + | n.d. | n.d. | Liver. | [ |
|
| n.d. | + | n.d. | Skin, gill and intestine. | [ | |
|
|
| + | n.d. | n.d. | Head-kidney, spleen and liver. | [ |
|
| n.d. | + | n.d. | Liver, spleen and head-kidney. | [ | |
|
|
| + | − | + | Skin. | [ |
|
|
| − | − | n.d. | Intestine and skin. | [ |
|
|
| n.d. | n.d. | + | Macrophages and neutrophils. | [ |
|
|
| n.d. | n.d. | + | Macrophages and neutrophils. | [ |
| n.d. | n.d. | +/− | Macrophages and larvae. | [ | ||
|
|
| n.d. | + | n.d. | Head-kidney leucocytes. | [ |
|
|
| − | n.d. | n.d. | Blood. | [ |
|
|
| − | n.d. | n.d. | Gills. | [ |
|
|
| − | − | n.d. | Skin and head-kidney. | [ |
|
|
| + | = | n.d. | Skin. | [ |
|
|
| + | + | n.d. | Skin. | [ |
|
| n.d. | −/= | n.d. | Gills and head-kidney. | [ |
1 Prokaryote bacteria or eukaryote parasites separated by line; 2 Expression of genes related to APP MHC class I pathways, APP MHC class II pathways or autophagy were (+) upregulated, (−) downregulated, (=) not modulated or (n.d.) not determined. 3 Human pathogen studied in zebrafish infection model.
Modulation of expression of genes involved in antigen processing and presentation (APP) MHC class I and II pathways and autophagy during vaccination of teleost fish species.
| Vaccine 1 | Host Species | MHC I 2 APP | MHC II 2 APP | Autophagy 2 | Organ or Cell | Reference |
|---|---|---|---|---|---|---|
|
|
| n.d. | + | n.d. | Kidney. | [ |
|
|
| + | − | n.d. | Liver and spleen. | [ |
|
|
| + | + | n.d. | Liver and spleen, kidney. | [ |
|
| + | + | n.d. | Liver and spleen. | [ | |
|
|
| + | + | n.d. | Spleen. | [ |
| VHSV |
| n.d. | n.d. | + | Fibroblast cell line and muscle. | [ |
| SVCV |
| n.d. | n.d. | + | Fibroblast cell line and muscle. | [ |
1 Vaccines addressed to the indicated pathogens. Spring viremia of carp virus (SVCV), Viral Hemorrhagic Septicemia Virus (VHSV); 2 Expression of genes related to APP MHC class I pathways, APP MHC class II pathways or autophagy were (+) upregulated, (−) downregulated or (n.d.) not determined.